MPM BioImpact’s Viridian Therapeutics VRDN Stock Holding History

MPM BioImpact’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$10.8M	Buy
2023 Q4	$2.18M	Sell
2023 Q3	$3.92M	Hold
2023 Q2	$6.07M	Buy